Mills & Reeve act on sale of Molecular Products Group to Arlington Capital Partners

Headquartered in Harlow, Essex MPG is a leading manufacturer of advanced chemistry-based products serving the healthcare, defence and industrial markets. The company primarily specialises in the manufacture and supply of chemical technologies for the treatment of breathable gases and is able to serve its global customer base out its two primary manufacturing facilities in Essex and Colorado in the US. 

MPG was majority owned by the McKernan family whose father established the company in 1973. Since 1995 it has been run by Ian and Andrew McKernan who have continued the family stewardship into its fifth decade. 

BGF’s investment in September 2014 helped the company to move into its new facility in Harlow, invest in new plant and equipment in both the UK and USA and accelerate its global expansion. 

With the acquisition by Arlington, Troy Rhudy, currently President MPG US, will take over the running of the group from Ian McKernan and Andrew McKernan. 

The sale comes at an exciting time for the company with a number of new products in development and follows a review of options and sale process carried out by Duff & Phelps Securities in London. 

Anthony McGurk, corporate finance partner who led the Mills & Reeve team said: ”We acted for MPG on the investment by BFG in 2014 and we have been delighted to work for all of the shareholders on this exciting transaction, which is testimony of the very successful business that has been built by the McKernan family over many years. “